Judges Scientific
Plc
("Judges
Scientific", "the Company" or "the Group")
Half Year Trading Update and
Notice of Interim Results
Judges Scientific (AIM:
JDG), the group focused on acquiring and developing companies
in the scientific instrument sector, provides the following
update regarding the Group's trading performance for the six-month
period ended 30 June 2024.
Trading in the first half of the
financial year, as indicated in the AGM update, has been
subdued against a backdrop of difficult market conditions and
versus record prior year comparatives. The challenging environment
has caused mixed trading across our Group.
We have continued to execute our
strategy, completing two small acquisitions during the
half: PE Fiberoptics acquired Luciol Instruments SA and Geotek
acquired Rockwash Geodata Limited.
References to "Organic" information in this update exclude any
contribution from Henniker Scientific Limited, Bossa Nova Vision
LLC and the two more recent acquisitions. Geotek is now included in
the Organic results.
Order intake
Across the Group, Organic order
intake was down 4% when compared against the strong H1 2023, which
was up 14% against H1 2022.
The challenging and variable
environment can be seen in Organic orders, with great contrasts
between our major trading regions, the most notable variations
being China/Hong Kong, down 65%, and North America also down
9%, contrasted by a 34% increase in the Rest of the World and 2%
improvement in Europe.
Order book
The Organic order book was
maintained at 17.2 weeks from its year end position (31 December
2023: 17.0 weeks; 30 June 2023: 22.4 weeks).
Revenue
Organic revenue in the first half
was down 3% compared with H1 2023, with the region most affected
being China/Hong Kong where revenues reduced by 9%. The 3% drop in
Organic revenue illustrated the effect of generally subdued order
intake, a few instances of a sharp reduction in demand and a small
number of significant projects being delayed to H2 or
2025.
Geotek's performance was lower than
H1 2023, which had included some residual income from its 2022
coring expedition. The extension of existing and entry into new
digitalisation contracts occurred too late to impact the H1
results meaningfully.
First Half Performance
The decrease in Organic revenues in
the first half is expected to result in earnings per share
declining by a fifth for the period. Our cash conversion rate
remained below the levels traditional for Judges and must remain a
key area of focus.
Outlook
The Board expects the second half to
show progress with the realisation of some delayed projects and
Geotek will benefit from the increased activity of its
digitalisation business. As highlighted at the time of our AGM
update in May, the next Geotek contract is in negotiation, and
specifies an expedition starting at the very end of 2024, implying
no recognisable revenue in the current financial year.
Despite the expectation of an
improved second half, the Board no longer expects the Group's
performance to recover sufficiently to enable us to deliver a
year-end performance in line with current market expectations*.
As a result, the Board now anticipates earnings per share to
be between 5 and 10% below the consensus*.
The Group still maintains a healthy
order book, and a solid financial position, which gives the Board
confidence that the subdued performance of the first half doesn't
hamper the Group's continuing strategy.
*
Current consensus market expectations for the year ended 31
December 2024 are Adjusted basic earnings per share of
384.6p.
Notice of Results
The Company intends to announce its
interim results for the six months to 30 June 2024 on
Thursday 19 September 2024.
This announcement contains inside information for the purposes
of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it
forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with
the Company's obligations under Article 17 of
MAR.
For further information please
contact:
Judges Scientific plc
David Cicurel, CEO
Brad Ormsby, CFO
Tel: +44 (0) 20 3829
6970
|
Shore Capital (Nominated Adviser & Joint
Broker)
Stephane Auton
Harry Davies-Ball
Tel: +44 (0) 20 7408 4090
|
|
Liberum (Joint Broker)
Edward Mansfield
Nikhil Varghese
Tel : +44 (0) 20 3100
2222
|
Investec Bank plc (Joint Broker)
Virginia Bull
Carlton Nelson
Tel: +44 (0) 20 7597 4000
|
|
Alma (Financial Public Relations)
Sam Modlin
Rebecca Sanders-Hewett
Joe Pederzolli
Tel: +44 (0) 20 3405 0205
judges@almastrategic.com
|
|
|
Notes to editors:
Judges Scientific plc (AIM:
JDG), is a group focused on acquiring and developing companies in
the scientific instrument sector. The Group now consists of
24 businesses acquired since 2005.
The acquired companies are
primarily UK-based with products sold worldwide to a diverse
range of markets including: higher education institutions,
scientific research facilities, manufacturers and regulatory
authorities. The UK is a recognised centre of
excellence for scientific instruments. The Group has received
five Queen's Awards for innovation and export.
The Group's companies predominantly
operate in global niche markets, with long term growth fundamentals
and resilient margins.
Judges Scientific maintains a
policy of selectively acquiring businesses that generate
sustainable profits and cash. Shareholder returns are created
through the reduction of debt, organic growth and
dividends.
For further information, please
visit www.judges.uk.com